SPAC Feed

Paris, 21 septembre 2026 – (Article 5 du règlement (UE) n° 596/2014 sur les abus de marché et Article 3 (3) du règlement délégué (UE) 2016/1052 complétant le règlement (UE) n° 596/2014 par des normes techniques de réglementation concernant les conditions applicables aux programmes de rachat et aux mesures de stabilisation).

Basel, 21 September 2026 – Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the European Commission has approved Susvimo® (ranibizumab 100 mg/mL solution for injection) for the treatment of neovascular age-related macular degeneration (nAMD), a leading cause of vision loss in people over the age of 60.^5,6 

Montrouge, le 21 septembre 2026

Drawing on 60-plus interviews, the research points to trusted information, stronger networks, and easier cross-border giving as the keys to greater impact.

Drawing on 60-plus interviews, the research points to trusted information, stronger networks, and easier cross-border giving as the keys to greater impact.

Northmarq announces the acquisition of Thirdline Capital Management, a registered investment advisor that manages the Thirdline Real Estate Income Fund.

Second campus under the Company’s 99 MW Alberta program; site offers 3 MW of grid power and a natural gas interconnection for behind-the-meter generation, planned as a 9.9 MW campus for AI and high-performance computing clients

GREENWICH, Conn., Sept. 21, 2026 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of freight transportation in North America, has been named to the 2027 FreightTech 100 list by FreightWaves, a global provider of supply chain market intelligence. XPO has been included on the FreightTech 100 every year since the inception of the list, which recognizes the most innovative companies in the freight transportation industry.

Selection comes as campus celebrates 60 years serving the Dallas-Fort Worth Area

Selection comes as campus celebrates 60 years serving the Dallas-Fort Worth Area

Not for distribution to U.S. newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, into the United States

Not for distribution to U.S. newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, into the United States

Tarrytown, New York, USA, Sept. 21, 2026 (GLOBE NEWSWIRE) —

Siemens Healthineers and Novo have announced a collaboration focused on advancing care for people living with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH). The companies are engaged in several projects to strengthen disease awareness, support earlier assessment of the disease, and help expand patient access to non-invasive blood testing.

Johnson & Johnson introduces the first IL-23R targeted oral peptide that can deliver skin clearance and a favourable safety profile in a once-daily pill.^1,2

Global Semiconductor Chip Ecosystem Market Size, Share, Revenue Trends & Segment by Communication, Application, Types of Companies, and Forecast 2026-2035.

FORM 8.3

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million.

First acquisition since its IPO: Ticketplus converts its white-label partner in Argentina into its own operation, with Autoentrada founder Eric López leading the local business

First acquisition since its IPO: Ticketplus converts its white-label partner in Argentina into its own operation, with Autoentrada founder Eric López leading the local business

Ascend Learning acquires M7, an AI-powered platform transforming how health systems schedule, staff and deploy their clinical workforce.

MELBOURNE, Australia and INDIANAPOLIS and MUNICH, Sept. 21, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE (“ITM”), a global leader in radioisotope production and radiopharmaceutical development.